The National Institute on Drug Abuse is launching its first large scale Prescription Opiate Addiction Treatment Study at 12 sites across the country, including the NYU/Bellevue primary-care clinic. The drug trials will test the effectiveness of buprenorphone/naloxone tablets - marketed as Suboxone - to break patients' addictions to painkillers such as Vicodin and OxyContin. The tablets will be accompanied by different levels of drug-abuse counseling, a key aspect of the study.
READ MORE @ New York Post
No comments:
Post a Comment